Skip to content
Relatix Bio

Relatix Bio

Radically different

  • Services
  • Knowledgebase
  • Partnerships
  • Our Approach
  • Contact
  • About
    • Vision
    • Our mission
    • Privacy Policy
    • FAQ
    • News
Posted on July 23, 2026 by admin

Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial

Nature Medicine, Published online: 22 July 2026; doi:10.1038/s41591-026-04593-2

Author Correction: Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial

CategoriesImported News TagsClinical trial, Medication

Post navigation

Previous PostPrevious Arterex Tecate opens ISO Class 8 clean room facility
Next PostNext Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells

This is the footer

Privacy Policy Proudly powered by WordPress